Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS3812854 A
Tipo de publicaciónConcesión
Fecha de publicación28 May 1974
Fecha de presentación20 Oct 1972
Fecha de prioridad20 Oct 1972
Número de publicaciónUS 3812854 A, US 3812854A, US-A-3812854, US3812854 A, US3812854A
InventoresR Buckles, M Keller, A Michaels
Cesionario originalR Buckles, M Keller, A Michaels
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Ultrasonic nebulizer
US 3812854 A
Resumen
A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
Imágenes(1)
Previous page
Next page
Reclamaciones  disponible en
Descripción  (El texto procesado por OCR puede contener errores)

ilnited States Patent Michaels et a1.

[ May 28, 1974 Primary Examiner-Richard A. Gaudet Assistant Examiner-Lee S. Cohen Attorney, Agent, or Firm-Thomas E. Ciotti; Edward L. Mandell; Paul L. Sabatine [57] ABSTRACT A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.

8 Claims, 3 Drawing Figures 1 1 ULTRASONIC NEBULIZER [76] lnventors: Alan S. Michaels, 97 Mt. Vernon,

Atherton; Richard G. Buckles, 491

Middle Ct., Menlo Park, both of Calif. 94025; Michael P. Keller, 2272 Latham St., Mountain View, Calif. 94040 [22] Filed: Oct. 20, 1972 [21] App]. No.: 299,194

[52] US. Cl 128/194, 128/D1G. 2, 239/102 [51] Int. Cl A6lm 15/00 [58] Field of Search 128/194, DIG. 2, 172, 173, 128/193, 145.8, 145.6; 259/D1G. 44; 239/102, 4, 338

[56] References Cited UNITED STATES PATENTS 2,658,169 11/1953 Barret 128/172 x 2 1&4

18 HIGH FREQUENCY G EN ERATOR RNTENIENNN RM I $812,854

/l4 [2 HIGH x FREQUENCY GENERATOR x LIQUID I N; IG.I F SUPPLY I? I LIQUID MOMMA l GENERATOR 16 I8 Y SUPPLY 1 ULTRASONM NEBULIZER BACKGROUND OF THE INVENTION 1. Field Of The Invention This invention relates to ultrasonic nebulizers. More particularly, it relates to a device for ultrasonically producing liquid aerosols having controlled particle size. In a preferred embodiment, the invention relates to an improved ultrasonic nebulizer for inhalation therapy.

2. The Prior Art The art is replete with processes which employ aerosols of liquids. Paints, biocides, personal and home care products, gas chromatography and spectroscopy samples, and inhalable drugs are representative of the many materials which are advantageously employed as aerosols. Most commonly, aerosols are generated by drawing the liquid into a high velocity stream of propellant gas. With the growing awareness of the health hazards posed by many of the known propellants, especially the Freon-type gases, other methods of generating aerosols are receiving increased attention.

It is known that aerosols can be generated ultrasonically. A common form of ultrasonic nebulizer achieves atomization by the disintegration of the geyser which is produced in a body of liquid by contacting the liquid with a focused beam of ultrasonic compressed wave energy. Devices of this type have been used, for example, in inhalation therapy (see U.S. Pat. No. 3,561,444 issued Feb. 9, l97l to Boucher or No. 3,387,607 issued June 1 1, 1968 to Gauthier et al.) and in sample atomization (see U.S. Pat. No. 3,325,976 issued June 20, 1967 to West). Another known type of ultrasonic nebulizer achieves atomization by dripping the liquid to be dispersed onto a continuously ultrasonically vibrating solid plate which breaks the liquid into a variety of particles. Such a device is shown in U.S. Pat. No. 3,291,122 issued Dec. 13, 1966 to Engstrom et al.

known that the point at which an aerosol particle deposits in the respiratory system is a function of particle size; micron particles are laid down in the mouth and larynx, 6 to 9 micron particles are preferentially.

deposited in the bronchi, 3 to 6 micron particles are preferentially deposited in the bronchioli, 1 to 3 micron particles are deposited in the alveoli, while particles much smaller than about 1-micron are not retained in the respiratory system by Brownian collision with all walls; most of these particles are exhaled.

Many respiratory diseases affect only one-of the areas of the respiratory system: for example, pneumonia and emphysema affect the alveoli, bronchitis affects the bronchioli, asthma affects the bronchi or bronchioli, etc. Since the drugs used to treat these diseases, for example, epinephrine, norepinephrine, prostaglandins, steroids, antibiotics, detergents and the like are often highly potent and/or systemically toxic, it would be of utmost advantage to minimize drug dosage by delivering the drug precisely to the affected area. More precise particle size control than possible heretofore would help minimize extraneous drug applications.

Another way to reduce drug dosage during inhalation therapy would be to deliver the drug as a precisely timed pulse. It has been found that the flow of gas in and out of the respiratory system has essentially plug flow characteristics with the first gas inspired eventually filling the most distant alveoli, the last gas inspired filling only the larynx, etc. Precise delivery of an accurately determined pulse of atomized drug at an accurately determined point during inspiration, thus would result in further control of the location of drug deposit.

Prior ultrasonic nebulizers are not suitable for accurate Both of these conventional types of nebulizing devices can effectively continuously produce large volumes of crude aerosol but both have three serious disadvantages when preceise nebulization is desired. First, they do not permit accurate control of the amount of liquid atomized; second, they also require relatively long times (often I to 10 seconds) after starting to generate a stable consistent aerosol, and finally, they fail to directly generate an aerosol having uniformly sized particles (so-called monodispersed aerosols).

This last failing is especially serious since it is often necessary or desirable to have a monodispersed aerosol. On a theoretical basis, it has been shown that continuous ultrasonic nebulizers should produce uniform particles related in diameter to the reciprocal of the ultrasonic frequency employed. In practice, however, prior ultrasonic atomizers have produced a variety of extraneous large particles which must be screened, settled or otherwise removed, albeit incompletely, as may be noted in U.S. Pat. No. 3,291,122 and Boucher et al. 26 Annals ofAllergy 591 at FIG. 4 (1968). This inability to control particle size has limited the usefulness of conventional ultrasonic nebulizers especially in inhalation treatment of the respiratory system where precise control of particle size is most advantageous and true monodispersed aerosols have been long desired.

The respiratory system comprises a series of decreasing diameter branched tubes, including the mouth, larynx, trachea, bronchi, bronchioli and alveoli. It is pulsed delivery. These devices often require at least several seconds of tuning to achieve a usable aerosol. When used in pulsed applications, conventional ultrasonic nebulizers rely upon interrupting the transmission of the aerosol by bulky ducts and poorly controllable valves rather than by controlling the aerosols generation.

OBJECTS OF THE INVENTION Accordingly, it is an object of the present invention to provide a new and improved nebulizer of the ultrasonic type.

A further object of this invention is to provide an ultrasonic nebulizer which will permit precise control of the amount of liquid nebulized.

A further object of this invention is to provide an ultrasonic nebulizer which will permit control of the size of liquid particles formed.

Another object of this invention is to provide a device for the production of aerosols which may be used with improved efficiency for inhalation therapy or other therapeutic purposes.

Yet another object of this invention is to provide an ultrasonic nebulizer for inhalation therapy which can be controlled to deliver a medicament-containing aerosol in the form of a pulse of particular particle size and amount of medicament; positioned at a particular point in the inspiration cycle.

STATEMENT OF THE INVENTION It has now been found that the foregoing objects, as well as other objects, advantages, and features which will become apparent from the detailed description to follow, are attained by a nebulizer which includes a porous body having a defined intercommunicating pore structure, an oscillator capable of vibrating the porous body at an ultrasonic frequency and a system for supplying liquid to be nebulized to the pores of the porous body.

BRIEF DESCRIPTION OF THE DRAWINGS In the drawings,,..wherein like reference numerals designate like parts:

FIG. 1 is an essentially diagrammatic cross-sectional view of an embodiment of the ultrasonic nebulizer of the invention;

FIG. 2 is an essentially diagrammatic cross-sectional view of another configuration of a nebulizer of the invention, and

FIG. 3 is a cross-sectional view of yet another configuration of the nebulizer of the invention.

DETAILED DESCRIPTION OF THE INVENTION As illustrated in FIG. 1, an ultrasonic nebulizer l embodying the present invention has a porous solid body 11 having a defined fixed intercommunicating pore structure. Solid body 11 is affixed to ultrasonic horn or antennuator 12 which is in turn attached to a suitable piezoelectric crystal or other electro-mechanical transducer 14. Crystal 14 is connected via cable 16 to high frequency signal generator which produces an ultrasonic signal of adequate power to oscillate crystal 14. The frequency generated by generator 15 is very suitably the resonant frequency of crystal 14 or a harmonic thereof. Cable 16, generator 15, crystal l4 and horn 12 in combination cause porous body 11 to vibrate at an ultrasonic frequency. Liquid to be nebulized is forced under pressure from liquid supply 17 through conduit 18 through concentric channel (or bore) 19 in horn 12 to the interconnected pores of porous body 11 which communicate with channel 19. Conduit 18 is attached to horn 12 in a manner which does not interfere with the ultrasonic oscillation of horn l2 and porous body 11. As will be appreciated by those skilled in the art, the embodiment of the invention illustrated in FIG. 1 is much simplified to clearly set out the invention. Details, such as for example a housing for the nebulizer or the method of flexibly attaching crystal 14 to the hous ing or the exact method of fastening conduit 18 to channel 19, may be supplied by one skilled in the art without departing from the spirit of this invention. Likewise, minor modifications, such as the addition of a capability for cooling crystal 14, may be employed.

In operation, liquid to be nebulized is passed through conduit 18 and channel 19 to porous body 11. The pores of body 11 are intercommunicating, so that liquid can be conducted through solid body 11. Thus the liquid from channel 19 moves to the outer surface of porous body 11 and there is nebulized by the ultrasonic vibration into an aerosol having a particle size distribution which is related to the diameters of the pores of body 11.

In accordance with the present invention, liquids are nebulized to aerosols using an ultrasonically vibrating porous body having a fixed pore structure. Unlike prior ultrasonic nebulizers wherein the size of the particles in the aerosol was determined by the frequency of the ultrasonic vibration, the particle sizes achieved with the instant nebulizers are related to the internal geometry of this porous body. Aerosol particle size is a function Particle diameter 2 X pore diameter For example, when a porous body having uniform 10 micron pores is used in the present invention, the aerosol particles which result are uniformly from about 18 to 22 microns in diameter. When a porous body having uniform 4 mircon diameter external surface pores is substituted an aerosol having particles from about 7 to 9 micron in diameter is formed. This particle size to pore diameter relationship appears to hold over the range of body external pore diameters of from about 0.5 micron to about 50 microns.

When a body having pores of a variety of sizes is employed, a multi-sized aerosol is obtained. In the preferred embodiments of this invention, wherein aerosols for inhalation therapy are produced, it is most often preferred to have uniform particle sizes. Bodies having uniform pore diameters in the range of from 0.5 to 5 microns produce aerosols ideal for many inhalation applications. Most specifically, bodies having all or a major proportion of their pores in the range of from 0.5 to 1.5 microns produce aerosols excellentfor inhalation treatment of the alveoli, bodies having their pores in the range of from 1.5 to 3 microns produce aerosols well suited for treating the bronchioli, while 3 to 5 micron pore bodies produce aerosols most useful for treating the bronchi. As used herein, a body is defined to have a uniform pore diameter within a range when at least about percent of all its pores fall within the given range. Preferably at least about percent of all the pores fit within the specified range.

The pores of the porous body must be joined into an intercommunicating network since when used in accord with this invention, liquid will be passed from one side of the porous body through to the other side.

To achieve reproducible results, the size of the outer pores of the porous body should be fixed. The material of construction of the porous body is not critical so long as it provides a fixed pore size. Porous ceramic oxides may be used as well as porous glasses and metal frits, compressed porous plastics, and certain filters (e.g., nucleopore). These materials are readily available, being used conventionally as filters and catalyst supports.

The porous body should be relatively thin, generally not more than about 1 or 2 cms thick, preferably from 0.01 to 1 cm thick. Undesirably large amounts of energy are required to force the liquid to be nebulized through thicker bodies.

The porous body may be comprised of several layers, for example an internal macroporous layer, which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution. Such a material can be made by carefully annealing or firing the surface of a macroporous support or by bonding a thin sheet of microporous ceramic, for example 0.005 cm thick, to a sheet of macroporous ceramic, for example 1 cm thick.

The porous body must be vibrated ultrasonically to produce the desired aerosol. This may be carried out by connecting the body to an ultrasonic vibrator such as, for example, by affixing the body to a piezoelectric ceramic crystal. This connection is preferably made through an antennuator horn, which when correctly matched to the piezoelectric crystal frequency, effeciently transmits the ultrasonic oscillation of the piezoelectric crystal to the porous body and if sized correctly permits the ultrasonic energy to be multiplied and focused in the porous body where nebulization occurs. The size and shape of the antennuator horn 12 is not critical. Ideally, it is sized taking into consideration its material and the velocity of ultrasonic waves therethrough to achieve a harmonic relationship at the frequency employed.

The porous body is attached or affixed to the antennuator horn by a method enabling a tight fit and firm attachment to be achieved. The exact method of affixing the porous body to the antennuator horn, while not critical, must be chosen with care. A tight fit must be achieved. Glueing or soldering can be used so long as the pores of the porous body are not blocked or appreciably obstructed. Clamping or threading the porous body to the antennuator horn are acceptable means of attachment.

The antennuator horn is attached to a piezoelectric ceramic crystal or transducer 14. Piezoelectric crystals and their use as transducers are well known. They may be made of materials such as lead zirconate or titanate, and calcium zironate or titanate, with or without traces of salts, for example yttrium, lanthanum, strontium or cobalt. To permit good electrical contact, they generally are coated on two opposite faces with electrically conducting metallic layers. A high frequency signal generator drives the piezoelectric crystal. This generator is capable of producing a signal having a frequency of from l5.00 kilohertz (Khz) to about 100.00 Khz. The power output required depends upon the amount of liquid being nebulized per unit time and the area and porosity of the porous body. As a general rule, at least 20,000 dyne-cm are needed to nebulize 1 cc of liquid into less than 20 micron particles. Best results are obtained when the power output is from about 1 X to about 1 X 10 dyne-cm.

Liquid to be nebulized is supplied to the porous body through channel 19 in antennuator horn 12. Channel 19 is illustrated as coaxial with horn 12. This is not critical. It is essential that channel 19 contact body 11 in a manner that the pores of body lll can communicate with channel 19 and that liquid passing through channel 19 can pass through the pores to the surface of body 11 and there be nebulized. Liquid is fed to channel 19 under pressure via conduit 17 from liquid supply 16. It is required that the liquid be fed under pressure if a substantial feed rate is to be achieved. The pressure employed will depend on the pore size of body 11, the viscosity of the liquid being fed, etc. Generally, pressure of from I to 20 psi are suitable and may be achieved by for example, moving the liquid with pumps, compressed gas cylinders and the like.

A great variety of liquids may be nebulized by an apparatus as illustrated in FIG. 1. Water and aqueous solutions, such as of drugs, herbicides, dilute paints and dyes and the like are suitable, as are non-aqueous liquids and solutions having viscosities not appreciably greater than about 500 centipoises. Viscous liquids, such as heavy oils, generally are not suitable for nebulization with the present apparatus as they tend to clog the porous body. Light organic materials such as lower hydrocarbons, oxyhydrocarbons and liquid halohydrocarbons may be easily nebulized for a variety of uses such as for flame spectrographic analysis and similar scientific investigations. Liquid medicaments, both neat and in aqueous and non-aqueous solutions which meet the above viscosity criteria are very suitably nebulized by the device of this invention.

Medicaments which may be administered to the respiratory tract by the present invention include conventional inhalation therapy substances such as bronchodilator decongestants, for example, epinephrine, isoproterenol, isoetharime and phenylephrine; moistening thinning and detergent solutions such as superinone; mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme; and water or saline humidity.

Turning now to FIG. 2, a diagrammatic illustration is given of an embodiment of the nebulizer of this invention adapted for use as an inhaler for inhalation therapy. The principle components of this inhaler inhaler 2) are the same as those of the nebulizer of FIG. 1, including porous body 11, antennuator horn l2, piezoelectric crystal 14, signal generator 15, cable 16 and liquid supply system 17, here shown as a pressure canister; connected to channel 19 via conduit 18. Inhaler 2 also has, in combination with the foregoing components, a mouthpiece 20 adapted at one end to fit the patients mouth and to admit air as well as medicament through its other end as illustrated, as well as means for automatically controlling the nebulizer during the respiration cycle. This automatic control includes an inspiration responsive detector 21, positioned in the airstream of mouthpiece 20, which reacts to changes in the velocity or pressure of the airstream within mouthpiece 20 thus signalling the commencement of inspiration to control 24 via means 22. Control 24 then opens valve 25 via line 26 and admits the desired amount of medicament from supply pressure canister 17, to line 18, channel 19 and porous body 11. Control 24 also turns on, via line 27, high frequency generator 15 which activates piezoelectric crystal 14 which ultrasonically vibrates horn 12 and attached porous body 11 to nebulize precisely the amount of medicament desired. Inhalation detector 21 and controller 24 may be set to deliver medicament throughout the inspiration cycle or in an especially advantageous mode of operation may be set to order a short burst (say from 0.1 to 1 second) of medication ata preset point during inspiration. This point may be based on the length of time from the start of inspiration or more preferably may be based on the volume of gas inspired. The volume may be simply derived by detecting and integrating the inspiration velocity. The nebulizer of this invention can produce a stable cosistant aerosol of uniform particle size essentially instantaneously, for example, within about 2 milliseconds. Thus it is possible to precisely-insert a burst of aerosolized medicament at any desired point in the inspiration cycle and therefore achieve much improved control of inhalation medicament delivery.

Although these constructional details are not illustrated, the inhaler of FIG. 2 can be constructed suitable for stationary or portable use. Because of the excellent direct control of particle size and amount of medicament nebulized, possible with the present invention, bulky filters, classifiers and the like are not required. Also, the electrical power demands of the inhaler of FIG. 2 are modest. Thus it can be constructed, if desired, to be battery operated in a highly portable form.

Turning now to FIG. 3, an embodiment of the invention, atomizer 3, suitable for generating bulk inhalation aerosols or for nebulizing liquid chemical samples for spectrographic or chromatographic analysis is shown. Atomizer 3 is similar to the embodiments of FIGS. 1 and 2 and includes porous body 11, which is here illustrated, not to scale, as a two layer body having a thin (0.05 cm) outer layer having the pore geometry which will give the particle size distribution desired the thicker (0.5 cm) inner layer having a macroporous structure adapted for the facile passage of liquid to be nebulized. Porous body 11 is attached to antennuator horn 12 by means of threaded compression collar 29. Horn 12 is attached to piezoelectric crystal 14 which is driven by ultrasonic oscillations generated by high frequency generator 15 and transmitted via cable 16. Liquid to be nebulized, for example water, is supplied under pressure by liquid supply 17 and line 18 to channel 19 on horn 12. Channel 19 is branched at its upper end where it contacts body 11. This facilitates the more ready passage and even distribution of liquid into body 11. The atomizer is mounted in housing 30, which is essentially sealed except for carrier gas inlet 31 and outlet 32. In operation, carrier gas, which for inhalation uses is usually air or oxygen containing a blend of gasses and for sample atomization is usually a noninterfering gas such as helium or nitrogen, is passed into housing 30 in inlet 31. A mixture of nebulized liquid and carrier gas is then withdrawn via outlet 32 and used as intended by means not shown.

- The following examples are merely illustrative of the present invention and are not to be considered as limiting the scope of the invention in any way.

EXAMPLE I An ultrasonic nebulizer, substantially as shown in FIG. I, is constructed. As porous body 11 is employed a 0.1 cm thick, 0.5 cm diameter disc of porous ceramic (aluminum oxide), having a relatively uniform porosity (some pores are as large as l or 12 microns, some are as small as about 4 microns) and a mean pore diameter of 6 microns. This body is glued on horn 12, care being taken to avoid blocking the pores of body 11. Antennuato'r horn 12 is constructed from brass and has the following dimensions: length, 3.12 inches, large diameter 0.45 inches, small diameter 0.20 inches. Channel 19 is coaxially bored in horn l2 and it has a diameter of 0.025 inches. A 0.50 inch piezoelectric ceramic is used as crystal [4. A Hewlett-Packard signal generator and McIntosh 2 l 00 Amplifier having a power output of 205 watts is employed as generator 15. Channel 19 is connected to a Harvard infusion pump. In operation, a 30.00 kilohertz oscillation of l8.2 watts power is applied to antennuator horn l2 and porous body 11. Water is pumped to porous body 11 at 20 psi pressure. The water nebulizes and is emitted from body 1 1 as an aerosol having particle diameters of from about 8 to about 20 microns corresponding to two times the diameter of the pores of body 11.

EXAMPLE 2 The experiment of Example I is repeated with one modification. As porous body 11 is employed a similarly sized disc of porous ceramic having a mean pore diameter of microns. The aerosol produced in this experiment has an average particle size of about microns.

EXAMPLE 3 The experiment of Example 1 is repeated with one modification. The antennuator horn having an internal bore and a porous ceramic tip is replaced with a solid horn having no ceramic tip. Liquid is fed to the end of the horn via an external 0.040 inch diameter'tube and a Harvard Positive Displacement pump, operated at 10 psi. An ultrasonic frequency varying from 25 KHz to KHz is applied, with energies of from X 10 400 X 10" dyne-cm. Throughout these ranges of frequencies and energies only randomly sized l0 70 micron particles of liquid are formed.

EXAMPLE 4 A series of experiments in accord with the experiment of Example 1 are conducted. In three experiments the liquid flow rate is varied from 0.0817 [Ll/SEC to 0.4l7 (Ll/Sec. The power requirement changes from 29 watts to 18 watts as the liquid feed is decreased. (all at 30 KHz). The particle size of the resulting aerosol remains constant averaging 15 microns.

In three additional experiments the glued porous body is replaced by a body of the same material attached by a threaded brass collar. Because of the resulting change in horn mass a new frequency (28 KHz) is found to be optimum. The aerosol particle sizes are the same as in the first three experiments. The power requirements at similar flow rates are reduced to form 18 to ll watts.

EXAMPLE 5 a. An inhaler substantially in accord with FIG. 2 is constructed. As liquid is employed a solution of medicament comprising epinephrine in distilled water. Controller 24 is set to order nebulization of medicament throughout the inspiration cycle. As porous body 11 is employed a glass frit having a uniform pore diameter of 5 to 6 microns. A patient inhales through mouthpiece 20. This flow of air is noted by detector 2]. Controller 24, responding to the signal of detector 21, then opens valve 25 and energizes high frequency generator 15 which in turn actuates crystal 14 which vibrates horn 12 and porous body 11. The medicament is nebulized into an aerosol having 10 to l2 micron particles which is inspired by the subject. These particles preferentially deposit on the throat and larynx of a patient employing the inhaler.

b. The experiment of part (a) is repeated using a 3 to 5 micron pore size glass frit. An aerosol having 6 to 10 micron particles is formed. This aerosol deposits preferentially in an inhaling patients bronchi.

c. Similarly, when a l to 2 micron frit is used, a 2 to 4 micron aerosol is formed, which deposits preferentially in a patients alveoli.

d. The experiment of part (c) is repeated with one change. Controller 24 is set to deliver only a short pulse of aerosol positioned at the initial portion of the inspiration cycle. In this case, the particles of medicament tiavell to and are primarily deposited in the most distant a V60 1.

EXAMPLE 6 A sample of lower ketones is to be analyzed by flame photometric detector gas chromatograph. An aerosolizer in accord with FIG. 3 is constructed using a bilayer ceramic porous body, the outer layer having an average 9 pore diameter of 2 microns, the inner having a 30 mircon average pore diameter. The mixed ketones are fed to the porous body, a suitable ultrasonic frequency is applied and a suitable carrier gas is fed via inlet 31. An aerosol of ketone is produced by the nebulizer and is carried therefrom by a carrier gas through the chromatograph to a flame photometeric detector where it is analyzed.

We claim as our invention:

1. An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination:

A. a porous solid body having a defined intercommunicating pore structure adapted to receive said liquid medicament, pass said liquid medicament through its pores and discharge said liquid medicament through one of its ends, the diameters of at least 75 percent of the pore openings in said one end being in the range of from 0.5 to 5 microns;

B. means for supplying said liquid medicament to said porous body; and

C. means for vibrating said porous body comprising:

2. The nebulizer according to claim 1 wherein at least 85 percent of said diameters are in said range.

3. The nebulizer according to claim 1 wherein the sizes of said particles are essentially twice the diameters of said pore openings.

4. The nebulizer according to claim 1 wherein the porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.

5. The nebulizer according to claim 1, said nebulizer being adapted to atomize the liquid medicament for inhalation by a patient and including:

D. a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.

6. An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.

7. An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication with the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and afiixed porous solid body at a frequency of from about 15 Khz to about Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.

8. An ultrasonic nebulizer according to claim 7 including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said air stream.

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US2658169 *14 Mar 19493 Nov 1953Centre Nat Rech ScientProduction of aerosols
US2949900 *2 Jun 195823 Ago 1960Albert G BodineSonic liquid sprayer
US3121534 *29 Sep 196018 Feb 1964Exxon Research Engineering CoSupersonic liquid atomizer and electronic oscillator therefor
US3214101 *31 Mar 196426 Oct 1965Little Inc AApparatus for atomizing a liquid
US3243122 *24 Feb 196529 Mar 1966Alvin A SnaperUltrasonic spray apparatus
US3400892 *2 Dic 196510 Sep 1968Battelle Development CorpResonant vibratory apparatus
US3561444 *22 May 19689 Feb 1971Bio Logics IncUltrasonic drug nebulizer
US3653379 *20 Ago 19704 Abr 1972Glenn Joseph GAdjustable pressure ippb ventilator
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US3912168 *30 Ene 197514 Oct 1975Teledyne Ind Inc Teledyne AquaIrrigation lavage
US4106503 *11 Mar 197715 Ago 1978Richard R. RosenthalMetering system for stimulating bronchial spasm
US4109863 *17 Ago 197729 Ago 1978The United States Of America As Represented By The United States Department Of EnergyApparatus for ultrasonic nebulization
US4119096 *24 Ago 197610 Oct 1978Siemens AktiengesellschaftMedical inhalation device for the treatment of diseases of the respiratory tract
US4261512 *20 Feb 198014 Abr 1981Boehringer Ingelheim GmbhInhalation aerosol spray device
US4292973 *3 Ene 19806 Oct 1981Kabushiki Kaisha Kurio-MedikaruApparatus for refrigeration treatment
US4348873 *23 Jun 198114 Sep 1982Kabushiki Kaisha Kurio-MedikaruApparatus for refrigeration treatment
US4412538 *31 Jul 19811 Nov 1983Kabushiki Kaisha Kurio-MedikaruApparatus for refrigeration treatment
US4541966 *24 Ago 198417 Sep 1985Penlon LimitedGas humidifying apparatus and method
US4546768 *14 Dic 198215 Oct 1985Feierabend GeorgInhalation apparatus for animals
US4648393 *2 Nov 198410 Mar 1987Ackrad Laboratories, Inc.Breath activated medication spray
US4776990 *14 Sep 198711 Oct 1988Rhinotherm Netzer SereniMethod and apparatus for nebulizing a liquid
US4815661 *3 Ago 198728 Mar 1989Tomtec N.V.Ultrasonic spraying device
US5063922 *27 Oct 198812 Nov 1991Etala-Hameen Keuhkovammayhdistys R.Y.Ultrasonic atomizer
US5139016 *29 Dic 198918 Ago 1992Sorin Biomedica S.P.A.Process and device for aerosol generation for pulmonary ventilation scintigraphy
US5152456 *3 Dic 19906 Oct 1992Bespak, PlcDispensing apparatus having a perforate outlet member and a vibrating device
US5221025 *24 May 199022 Jun 1993Conceptair AnstaltMethod and mechanical, electrical, or electronic apparatus for dispensing, issuing, or diffusing medicines, fragrances or other liquid or visous substances in the liquid phase or in the gaseous phase
US5259254 *25 Sep 19919 Nov 1993Cetac Technologies, Inc.Sample introduction system for inductively coupled plasma and other gas-phase, or particle, detectors utilizing ultrasonic nebulization, and method of use
US5261601 *6 Jul 199216 Nov 1993Bespak PlcDispensing a liquid as an atomised spray
US5392648 *17 Dic 199128 Feb 1995Minnesota Mining And Manufacturing CompanyDevice for measuring a pre-determined volume of liquid flowing therethrough
US5407424 *24 Feb 199318 Abr 1995Scimed Life Systems, Inc.Angioplasty perfusion pump
US5443059 *14 Ene 199422 Ago 1995Dragerwerk AgUltrasonic atomizer with a metering unit
US5487378 *17 Dic 199130 Ene 1996Minnesota Mining And Manufacturing CompanyFor dispensing droplets of liquid medicament to a patient
US5497763 *14 Dic 199312 Mar 1996Aradigm CorporationTo the lungs
US5507277 *28 Oct 199416 Abr 1996Aradigm CorporationLockout device for controlled release of drug from patient-activateddispenser
US5509404 *11 Jul 199423 Abr 1996Aradigm CorporationInto a patient's airway
US5518179 *4 Dic 199221 May 1996The Technology Partnership LimitedFluid droplets production apparatus and method
US5522385 *27 Sep 19944 Jun 1996Aradigm CorporationDynamic particle size control for aerosolized drug delivery
US5529055 *27 May 199425 Jun 1996L'orealPiezoelectric nebulizing apparatus
US5544646 *20 May 199413 Ago 1996Aradigm CorporationSystems for the intrapulmonary delivery of aerosolized aqueous formulations
US5558085 *28 Oct 199424 Sep 1996Aradigm CorporationIntrapulmonary delivery of peptide drugs
US5586550 *31 Ago 199524 Dic 1996Fluid Propulsion Technologies, Inc.Apparatus for nebulizing a liquid
US5660166 *10 Abr 199626 Ago 1997Aradigm CorporationSystems for the intrapulmonary delivery of aerosolized aqueous formulations
US5672581 *28 Oct 199430 Sep 1997Aradigm CorporationDrug delivery; aerosol, programmed, portable, disposable
US5694919 *27 Oct 19959 Dic 1997Aradigm CorporationHand-held, portable, self-contained aerosol drug delivery system
US5709202 *21 May 199320 Ene 1998Aradigm CorporationIntrapulmonary delivery of aerosolized formulations
US5718222 *30 May 199517 Feb 1998Aradigm CorporationDisposable package for use in aerosolized delivery of drugs
US5724957 *28 Jul 199510 Mar 1998Aradigm CorporationMethod of administering an analgesic drug
US5735263 *15 Abr 19967 Abr 1998Aradigm CorporationLockout device for controlled release of drug from patient-activated dispenser
US5743250 *22 Nov 199628 Abr 1998Aradigm CorporationInsulin delivery enhanced by coached breathing
US5758637 *21 Feb 19962 Jun 1998Aerogen, Inc.Apparatus for nebulizing a liquid
US5771882 *9 Sep 199630 Jun 1998Siemens Elema AbAnesthetic administration apparatus which delivers anesthetic in microdroplets
US5792057 *26 Nov 199711 Ago 1998Aradigm CorporationMethod of creating an image
US5819726 *4 Feb 199713 Oct 1998Aradigm CorporationMethod for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
US5823178 *2 Ago 199620 Oct 1998Aradigm CorporationDisposable package for use in aerosolized delivery of drugs
US5826570 *23 Abr 199727 Oct 1998Aradigm CorporationHand held device for delivering aerosolized medication to a patient
US5829436 *27 Ene 19973 Nov 1998Aradigm CorporationVentilation imaging using a fine particle aerosol generator
US5873358 *29 Abr 199823 Feb 1999Aradigm CorporationInhaling
US5884620 *25 Abr 199723 Mar 1999Aradigm CorporationInhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5888477 *31 Ene 199730 Mar 1999Aradigm CorporationUse of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US5910301 *7 Mar 19978 Jun 1999Aradigm CorporationMethod of intrapulmonary administration of a narcotic drug
US5915378 *27 Oct 199529 Jun 1999Aradigm CorporationCreating an aerosolized formulation of insulin
US5934272 *27 Oct 199510 Ago 1999Aradigm CorporationDevice and method of creating aerosolized mist of respiratory drug
US5938117 *5 Abr 199517 Ago 1999Aerogen, Inc.Methods and apparatus for dispensing liquids as an atomized spray
US5941240 *25 Sep 199824 Ago 1999Aradigm CorporationInhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US5950619 *14 Mar 199614 Sep 1999Siemens AktiengesellschaftFor atomizing a fluid
US5957124 *27 Sep 199528 Sep 1999Aradigm CorporationDynamic particle size control for aerosolized drug delivery
US5960792 *27 Oct 19955 Oct 1999Aradigm CorporationDevice for aerosolized delivery of peptide drugs
US5970973 *29 Abr 199826 Oct 1999Aradigm CorporationMethod of delivering insulin lispro
US5970974 *14 Mar 199626 Oct 1999Siemens AktiengesellschaftDosating unit for an ultrasonic atomizer device
US6012450 *1 Jul 199611 Ene 2000Aradigm CorporationIntrapulmonary delivery of hematopoietic drug
US6014969 *26 Oct 199818 Ene 2000Aradigm CorporationDisposable package for use in aerosolized delivery of antibiotics
US6014970 *11 Jun 199818 Ene 2000Aerogen, Inc.Methods and apparatus for storing chemical compounds in a portable inhaler
US6024090 *1 Jun 199815 Feb 2000Aradigm CorporationMethod of treating a diabetic patient by aerosolized administration of insulin lispro
US6085740 *10 Abr 199811 Jul 2000Aerogen, Inc.Liquid dispensing apparatus and methods
US6085753 *22 Abr 199811 Jul 2000Aradigm CorporationInsulin delivery enhanced by coached breathing
US6098615 *29 Abr 19988 Ago 2000Aradigm CorporationMethod of reproducibly effecting a patient's glucose level
US6098620 *27 Oct 19958 Ago 2000Aradigm CorporationDevice for aerosolizing narcotics
US6116233 *28 Feb 199512 Sep 2000Medic-Aid LimitedDrug delivery arrangement
US6123068 *24 Abr 199826 Sep 2000Aradigm CorporationSystems for the intrapulmonary delivery of aerosolized aqueous formulations
US6131567 *8 Ene 199817 Oct 2000Aradigm CorporationMethod of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US6138668 *26 Nov 199731 Oct 2000Inhale Therpeutic SystemsMethod and device for delivering aerosolized medicaments
US616788020 Ago 19992 Ene 2001Aradigm CorporationInhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US619287629 Jul 199827 Feb 2001Astra AktiebolagInhalation apparatus and method
US62059998 Sep 199827 Mar 2001Aerogen, Inc.Methods and apparatus for storing chemical compounds in a portable inhaler
US62351779 Sep 199922 May 2001Aerogen, Inc.Method for the construction of an aperture plate for dispensing liquid droplets
US62502987 Sep 200026 Jun 2001Aradigm CorporationMethod of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US6260549 *18 Jun 199817 Jul 2001Clavius Devices, Inc.Breath-activated metered-dose inhaler
US6318361 *1 Oct 199920 Nov 2001Clavius Devices Inc.Breath-activated metered-dose inhaler
US640885421 Abr 200025 Jun 2002Aradigm CorporationInsulin delivery enhanced by coached breathing
US642768121 Jun 20016 Ago 2002Aradigm CorporationMethod of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US643116615 Feb 200113 Ago 2002Aradigm CorporationAerosols; controlling lung delivery
US6431167 *9 Oct 200113 Ago 2002Aradigm CorporationAerosols; controlling lung delivery
US646747618 May 200022 Oct 2002Aerogen, Inc.Liquid dispensing apparatus and methods
US653037016 Sep 199911 Mar 2003Instrumentation Corp.Nebulizer apparatus
US653993712 Abr 20001 Abr 2003Instrumentarium Corp.Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
US654015327 May 19991 Abr 2003Aerogen, Inc.Methods and apparatus for dispensing liquids as an atomized spray
US654344312 Jul 20008 Abr 2003Aerogen, Inc.Methods and devices for nebulizing fluids
US654344830 May 20008 Abr 2003Inhale Therapeutic Systems, Inc.Apparatus and methods for dispersing dry powder medicaments
US654692713 Mar 200115 Abr 2003Aerogen, Inc.Methods and apparatus for controlling piezoelectric vibration
US65469294 Jun 200115 Abr 2003Inhale Therapeutic Systems, Inc.Dry powder dispersing apparatus and methods for their use
US655047216 Mar 200122 Abr 2003Aerogen, Inc.Devices and methods for nebulizing fluids using flow directors
US65542012 May 200129 Abr 2003Aerogen, Inc.Insert molded aerosol generator and methods
US659860219 Jun 200029 Jul 2003Siemens-Elema AbMedical nebulizer
US6606989 *8 May 199819 Ago 2003Gsf-Forschungszentrum Fur Umwelt Und Gesundheit GmbhPrecise administration of a medicated aerosol via the lungs
US66296467 Dic 19937 Oct 2003Aerogen, Inc.Droplet ejector with oscillating tapered aperture
US664080415 Ago 20024 Nov 2003Aerogen, Inc.Liquid dispensing apparatus and methods
US664798718 Jun 200218 Nov 2003Aradigm CorporationInsulin delivery enhanced by coached breathing
US6651650 *9 Abr 199325 Nov 2003Omron CorporationUltrasonic atomizer, ultrasonic inhaler and method of controlling same
US6655376 *18 Nov 19992 Dic 2003Pneumoflex Systems L.L.C.Aspiration screening process for assessing post surgery patient's risk for pneumonia
US6679249 *30 Ago 200120 Ene 2004Pneumoflex Systems, L.L.C.Apparatus for treatment of chronic obstructive pulmonary disease and associated method
US66817671 May 200027 Ene 2004Nektar TherapeuticsMethod and device for delivering aerosolized medicaments
US6688304 *10 Sep 200110 Feb 2004Aradigm CorporationInhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US6729334 *10 Mar 19994 May 2004Trudell Medical LimitedNebulizing catheter system and methods of use and manufacture
US67329442 May 200111 May 2004Aerogen, Inc.Base isolated nebulizing device and methods
US675518918 May 199929 Jun 2004Aerogen, Inc.Methods and apparatus for storing chemical compounds in a portable inhaler
US676962630 Oct 20003 Ago 2004Instrumentarium Corp.Device and method for detecting and controlling liquid supply to an apparatus discharging liquids
US678288620 Mar 200131 Ago 2004Aerogen, Inc.Metering pumps for an aerosolizer
US684577015 Ene 200325 Ene 2005Aerogen, Inc.Systems and methods for clearing aerosols from the effective anatomic dead space
US68896908 May 200310 May 2005Oriel Therapeutics, Inc.Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US690192919 Dic 20027 Jun 2005Nektar TherapeuticsAerosolization; comprises pressurization cylinders; drug delivery
US69262082 May 20039 Ago 2005Aerogen, Inc.Droplet ejector with oscillating tapered aperture
US694849120 Mar 200127 Sep 2005Aerogen, Inc.Convertible fluid feed system with comformable reservoir and methods
US697877919 Abr 200227 Dic 2005Instrumentarium Corp.Vibrating element liquid discharging apparatus having gas pressure sensing
US69789419 Abr 200427 Dic 2005Aerogen, Inc.Base isolated nebulizing device and methods
US698579826 Jun 200310 Ene 2006Oriel Therapeutics, Inc.Dry powder dose filling systems and related methods
US7021309 *8 Oct 20034 Abr 2006Aradigm CorporationMethod of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US7028686 *4 Nov 200318 Abr 2006Aradigm CorporationInhaled insulin dosage control delivery enhanced by controlling total inhaled volume
US70325905 Ene 200425 Abr 2006Aerogen, Inc.Fluid filled ampoules and methods for their use in aerosolizers
US704054921 Mar 20039 May 2006Aerogen, Inc.Systems and methods for controlling fluid feed to an aerosol generator
US706639830 Mar 200127 Jun 2006Aerogen, Inc.Aperture plate and methods for its construction and use
US70831126 Jun 20051 Ago 2006Aerogen, Inc.Method and apparatus for dispensing liquids as an atomized spray
US710060020 Mar 20015 Sep 2006Aerogen, Inc.Fluid filled ampoules and methods for their use in aerosolizers
US71044636 Oct 200512 Sep 2006Aerogen, Inc.Base isolated nebulizing device and methods
US7108197 *9 May 200519 Sep 2006Aerogen, Inc.Droplet ejector with oscillating tapered aperture
US711801026 Jun 200310 Oct 2006Oriel Therapeutics, Inc.Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US71748885 Sep 200313 Feb 2007Aerogen, Inc.Liquid dispensing apparatus and methods
US719501130 Jun 200427 Mar 2007Aerogen, Inc.Convertible fluid feed system with comformable reservoir and methods
US7201163 *7 Ene 200310 Abr 2007The Brigham And Women's Hospital, Inc.Method for altering the body temperature of a patient using a nebulized mist
US7201167 *14 Mar 200510 Abr 2007Aerogen, Inc.Method and composition for the treatment of lung surfactant deficiency or dysfunction
US7267121 *30 Sep 200411 Sep 2007Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US7290541 *30 Jun 20046 Nov 2007Aerogen, Inc.Aerosol delivery apparatus and method for pressure-assisted breathing systems
US730678712 Mar 200211 Dic 2007Nektar TherapeuticsEngineered particles and methods of use
US7322349 *18 Jun 200329 Ene 2008Aerogen, Inc.Apparatus and methods for the delivery of medicaments to the respiratory system
US733133923 Nov 200419 Feb 2008Aerogen, Inc.Methods and systems for operating an aerosol generator
US73605367 Ene 200322 Abr 2008Aerogen, Inc.Devices and methods for nebulizing fluids for inhalation
US737727721 Oct 200427 May 2008Oriel Therapeutics, Inc.Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US74220139 Mar 20059 Sep 2008Nektar TherapeuticsDry powder dispersing apparatus and methods for their use
US742844612 Jul 200523 Sep 2008Oriel Therapeutics, Inc.Dry powder dose filling systems and related methods
US744837517 May 200511 Nov 2008Aradigm CorporationMethod of treating diabetes mellitus in a patient
US745176121 Oct 200418 Nov 2008Oriel Therapeutics, Inc.Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US745837230 Oct 20032 Dic 2008Pari Pharma GmbhInhalation therapy device
US746970025 Jun 200330 Dic 2008Trudell Medical LimitedNebulizing catheter system for delivering an aerosol to a patient
US747270525 Jun 20036 Ene 2009Trudell Medical LimitedMethods of forming a nebulizing catheter
US7490603 *21 Nov 200517 Feb 2009Aradigm CorporationMethod of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US752027826 Ene 200521 Abr 2009Oriel Therapeutics, Inc.Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US760051130 Oct 200213 Oct 2009Novartis Pharma AgApparatus and methods for delivery of medicament to a respiratory system
US7622510 *15 Oct 200324 Nov 2009Christophe ArnaudMethod and device for making a dispersion or an emulsion
US76283395 May 20068 Dic 2009Novartis Pharma AgSystems and methods for controlling fluid feed to an aerosol generator
US762897819 Ago 20038 Dic 2009Novartis Pharma AgStabilized preparations for use in metered dose inhalers
US767741127 Jun 200316 Mar 2010Oriel Therapeutics, Inc.Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US7677467 *20 Abr 200516 Mar 2010Novartis Pharma AgMethods and devices for aerosolizing medicament
US7712680 *30 Ene 200611 May 2010Sono-Tek CorporationUltrasonic atomizing nozzle and method
US774837730 Oct 20076 Jul 2010Novartis AgMethods and systems for operating an aerosol generator
US77716421 Abr 200510 Ago 2010Novartis AgMethods of making an apparatus for providing aerosol for medical treatment
US787159810 May 200018 Ene 2011Novartis Agexhibit improved stability and dispersability over the shelf life of the composition; microparticles are simple to produce without the need of the formation of an emulsion or the use of an oil as a blowing agent
US788303120 May 20048 Feb 2011James F. Collins, Jr.Ophthalmic drug delivery system
US79145171 Nov 200429 Mar 2011Trudell Medical InternationalSystem and method for manipulating a catheter for delivering a substance to a body cavity
US793121231 Jul 200326 Abr 2011Pari Pharma GmbhFluid droplet production apparatus and method
US7946291 *20 Abr 200424 May 2011Novartis AgVentilation systems and methods employing aerosol generators
US79588878 Mar 200714 Jun 2011Aradigm CorporationNozzle pore configuration for intrapulmonary delivery of aerosolized formulations
US797158824 Mar 20055 Jul 2011Novartis AgMethods and systems for operating an aerosol generator
US801213626 Ene 20076 Sep 2011Optimyst Systems, Inc.Ophthalmic fluid delivery device and method of operation
US816196921 Mar 200824 Abr 2012Novartis AgDry powder dispersing apparatus and methods for their use
US816822321 Jun 20011 May 2012Novartis Pharma AgEngineered particles and methods of use
US819657323 Ene 200812 Jun 2012Novartis AgMethods and systems for operating an aerosol generator
US820155413 Mar 200919 Jun 2012Injet Digital Aerosols LimitedInhalation device having an optimized air flow path
US82469343 Sep 201021 Ago 2012Novartis AgRespiratory dispersion for metered dose inhalers comprising perforated microstructures
US833202028 Ene 201111 Dic 2012Proteus Digital Health, Inc.Two-wrist data gathering system
US833654516 Ene 200725 Dic 2012Novartis Pharma AgMethods and systems for operating an aerosol generator
US834817715 Jun 20098 Ene 2013Davicon CorporationLiquid dispensing apparatus using a passive liquid metering method
US834929414 Dic 20108 Ene 2013Novartis AgStable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US83712909 Oct 200812 Feb 2013General Electric CompanyDevice for delivery and regulation of volatile fluids into inspiratory gas
US837129910 Abr 200812 Feb 2013Respironics Respiratory Drug DeliveryVentilator aerosol delivery
US839800119 Jun 200619 Mar 2013Novartis AgAperture plate and methods for its construction and use
US840421722 Jul 200526 Mar 2013Novartis Agantifungal administered via inhalation; good dispersibility and storage stability; efficiently delivered to the deep lung; treating pulmonary aspergillosis with amphotericin B-containing formulations
US841963818 Nov 200816 Abr 2013Proteus Digital Health, Inc.Body-associated fluid transport structure evaluation devices
US85115818 Mar 201120 Ago 2013Pari Pharma GmbhFluid droplet production apparatus and method
US85399448 Abr 200824 Sep 2013Novartis AgDevices and methods for nebulizing fluids for inhalation
US854546326 Ene 20071 Oct 2013Optimyst Systems Inc.Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
US856160412 Feb 200722 Oct 2013Novartis AgLiquid dispensing apparatus and methods
US857893118 Abr 200012 Nov 2013Novartis AgMethods and apparatus for storing chemical compounds in a portable inhaler
US861619527 Abr 200431 Dic 2013Novartis AgNebuliser for the production of aerosolized medication
US868498015 Jul 20111 Abr 2014Corinthian Ophthalmic, Inc.Drop generating device
US870948424 Oct 200829 Abr 2014Novartis AgPhospholipid-based powders for drug delivery
US871562331 Oct 20076 May 2014Novartis AgPulmonary delivery of aminoglycoside
US8733343 *29 Oct 200727 May 2014Universidad De SevillaDevice and method for creating aerosols for drug delivery
US873393515 Jul 201127 May 2014Corinthian Ophthalmic, Inc.Method and system for performing remote treatment and monitoring
US20090288659 *13 May 200926 Nov 2009Heikki HaveriApparatus, system and method for administering an anesthetic agent for a subject breathing
US20130108748 *31 Oct 20122 May 2013Pepsico., Inc.Dispensing Nozzle with an Ultrasound Activator
DE4300880A1 *15 Ene 199321 Jul 1994Draegerwerk AgUltraschallvernebler mit Dosiereinheit
EP0156409A2 *18 Feb 19852 Oct 1985Jean Michel AnthonyDevice for moistening parts of the human body
EP0186280A2 *25 Oct 19852 Jul 1986Robert LandisBreath activated medication spray
EP0200258A2 *17 Abr 19865 Nov 1986Jean Michel AnthonyUltrasonic spraying device
EP0232235A2 *23 Ene 198712 Ago 1987A/S GEA Farmaceutisk FabrikMedical dosing device for discharge of atomized medicament for inhalation air
EP0642802A2 *5 Ago 199415 Mar 1995Disetronic AgInhalation device
EP0844027A1 *5 Ago 199627 May 1998Omron CorporationAtomization apparatus and method utilizing surface acoustic waves
EP1066850A1 *28 Abr 200010 Ene 2001Siemens Elema ABMedical Nebulizer
EP1219313A129 Dic 20003 Jul 2002Instrumentarium CorporationLiquid discharging apparatus and magneto-shape-memory type valve
EP1219314A129 Dic 20003 Jul 2002Instrumentarium CorporationLiquid discharge apparatus having magnetic valve
EP1227856A1 *27 Oct 20007 Ago 2002PARI GmbH Spezialisten für effektive InhalationInhalation nebulizer
EP1310268A2 *10 Jul 199514 May 2003Aradigm CorporationIntrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
EP1694392A2 *24 Nov 200430 Ago 2006Robert E. CoifmanDevices for measuring inspiratory airflow
EP2050478A1 *16 Oct 200722 Abr 2009GE Healthcare Finland OyDevice for delivery and regulation of volatile fluids into inspiratory gas
EP2050479A2 *20 May 200822 Abr 2009General Electric CompanyApparatus, system and method for admistering an anesthetic agent for a subject breathing
EP2119465A1 *16 May 200818 Nov 2009Markos Mefar S.P.A.Nebulizer with breathing phase detecting sensor for delivering nebulized drugs to a user
WO1989006147A1 *27 Oct 198813 Jul 1989Etelae Haemeen KeuhkovammayhdiUltrasonic atomizer
WO1992011050A1 *17 Dic 19919 Jul 1992Minnesota Mining & MfgInhaler
WO1992011512A1 *17 Dic 19919 Jul 1992Minnesota Mining & MfgDevice for measuring a pre-determined volume of liquid flowing there through
WO1996001663A1 *10 Jul 199525 Ene 1996Aradigm CorpIntrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
WO1996013290A1 *27 Oct 19959 May 1996Aradigm CorpDevice for aerosolized delivery of peptide drugs
WO1996013291A1 *27 Oct 19959 May 1996Aradigm CorpDevice for aerosolizing narcotics
WO1996013292A1 *27 Oct 19959 May 1996Aradigm CorpDevice and method of creating aerosolized mist of respiratory drug
WO1996028205A1 *14 Mar 199619 Sep 1996Siemens AgUltrasonic atomizer device with removable precision dosing unit
WO1996028206A1 *14 Mar 199619 Sep 1996Siemens AgUltrasonic atomizer device with removable precision dosating unit
WO1996030068A1 *15 Mar 19963 Oct 1996Aradigm CorpIntrapulmonary delivery of hematopoietic drug
WO1996031289A13 Abr 199610 Oct 1996Fluid Propulsion Techn IncMethods and apparatus for dispensing liquids as an atomized spray
WO1997018846A1 *18 Nov 199629 May 1997R & D Injector AgNebulizing device
WO1997031721A1 *27 Feb 19974 Sep 1997Hopkins Andrew DavidA nebuliser
WO2001019437A18 Sep 200022 Mar 2001Instrumentarium CorpNebulizer apparatus
WO2001032246A1 *3 Nov 200010 May 2001Pari GmbhInhalation nebuliser
WO2001076762A24 Abr 200118 Oct 2001Instrumentarium CorpMethod of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus
WO2002036269A112 Oct 200110 May 2002Instrumentarium CorpDevice and method for detecting and controlling liquid supply to an apparatus discharging liquid
WO2002087772A1 *1 May 20027 Nov 2002Aerogen IncCymbal-shaped actuator for a nebulizing element
WO2003059423A1 *15 Ene 200324 Jul 2003Aerogen IncSystems and methods for clearing aerosols from the effective anatomic dead space
WO2005011574A2 *23 Jul 200410 Feb 2005Robert E CoifmanMicroporous membrane nebulizers
WO2005051177A2 *24 Nov 20049 Jun 2005Robert E CoifmanDevices for measuring inspiratory airflow
WO2005102431A2 *20 Abr 20053 Nov 2005Aerogen IncAerosol delivery apparatus for pressure assisted breathing
WO2007106386A29 Mar 200720 Sep 2007Aradgim CorpNozzle pore configuration for intrapulmonary delivery of aerosolized formulations
WO2012156724A216 May 201222 Nov 2012The Technology Partnership PlcSeparable membrane improvements
Clasificaciones
Clasificación de EE.UU.128/200.16, 239/102.2
Clasificación internacionalB05B17/06, A61M15/00, A61M11/00
Clasificación cooperativaB05B17/063, B05B17/0623, A61M15/0085, A61M2011/001
Clasificación europeaB05B17/06B2B, A61M15/00F, B05B17/06B2